Andrew Davis

Andrew Davis

Corporate Officer/Principal bij DYNAVAX TECHNOLOGIES CORPORATION
40 jaar
Health Technology
Consumer Services

Profiel

Andrew Davis is currently Director at UTILITY therapeutics Ltd. since 2019 and Chief Business Officer at Dynavax Technologies Corp.
starting in 2024.
Formerly, Mr. Davis was Chairman at VectivBio Holding AG; Director at BioMarck Pharmaceuticals Ltd. from 2020 to 2022; Senior Vice President-Business Development at Ironwood Pharmaceuticals, Inc. in 2021; Senior Vice President-Business Development at Bausch Health US LLC from 2014 to 2016; Vice President-Corporate Development at Bausch Health Cos., Inc.; Chief Business Development Officer at iNova Pharmaceuticals (Pty) Ltd. (South Africa) from 2017 to 2021; and Head-Oncology Business Development at Merck & Co., Inc. from 2016 to 2017.
Education includes undergraduate studies at Boston University.

Actieve functies van Andrew Davis

BedrijvenFunctieBegin
DYNAVAX TECHNOLOGIES CORPORATION Corporate Officer/Principal 01-11-2024
Directeur/Bestuurslid 01-08-2019

Eerdere bekende functies van Andrew Davis

BedrijvenFunctieEinde
IRONWOOD PHARMACEUTICALS, INC. Corporate Officer/Principal 22-11-2024
Directeur/Bestuurslid 01-10-2022
Corporate Officer/Principal 01-05-2021
MERCK & CO., INC. Corporate Officer/Principal 01-09-2017
Corporate Officer/Principal 01-01-2016
Ervaring van Andrew Davis in detail bekijken

Opleiding van Andrew Davis

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

15

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit10

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Andrew Davis